Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Djulis Hull Enhances the Efficacy of Ferric Citrate Supplementation via Restoring Normal Iron Efflux through the IL-6-Hepcidin-Ferroportin Pathway in High-Fat-Diet-Induced Obese Rats.
Faradina A, Tung YT, Chen SH, Liao YC, Chou MJ, Teng IC, Lin WL, Wang CC, Sheu MT, Chou PY, Shih CK, Skalny AV, Tinkov AA, Chang JS. Faradina A, et al. Among authors: lin wl. J Agric Food Chem. 2023 Nov 8;71(44):16691-16701. doi: 10.1021/acs.jafc.3c02826. Epub 2023 Oct 25. J Agric Food Chem. 2023. PMID: 37877289
Weight loss induced by a hypocaloric diet with or without fish oil supplementation re-established iron and omega-3 fatty acid homeostasis in middle-aged women with obesity: A post-hoc analysis of a randomized controlled trial.
Huang SY, Mayasari NR, Tung TH, Lin WL, Tseng SH, Chang CC, Huang HY, Chang JS. Huang SY, et al. Among authors: lin wl. Maturitas. 2024 Jun;184:107948. doi: 10.1016/j.maturitas.2024.107948. Epub 2024 Feb 24. Maturitas. 2024. PMID: 38447232 Clinical Trial.
Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study.
Xie SH, Yang LT, Zhang H, Tang ZL, Lin ZW, Chen Y, Hong ZN, Xu RY, Lin WL, Kang MQ. Xie SH, et al. Among authors: lin wl. Front Immunol. 2024 Feb 5;15:1332492. doi: 10.3389/fimmu.2024.1332492. eCollection 2024. Front Immunol. 2024. PMID: 38375480 Free PMC article.
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial.
Sum CH, Li TW, Zhang H, Hung HY, Fong BYF, Lin WL, Chow TY, Leung KC, Lo CW, Chia CP, Chan KL, Lin ZX. Sum CH, et al. Among authors: lin wl. Front Pharmacol. 2024 Jan 8;14:1261338. doi: 10.3389/fphar.2023.1261338. eCollection 2023. Front Pharmacol. 2024. PMID: 38259270 Free PMC article.
573 results